CN1471580A - 含有外源性内表位的病毒颗粒 - Google Patents
含有外源性内表位的病毒颗粒 Download PDFInfo
- Publication number
- CN1471580A CN1471580A CNA008167532A CN00816753A CN1471580A CN 1471580 A CN1471580 A CN 1471580A CN A008167532 A CNA008167532 A CN A008167532A CN 00816753 A CN00816753 A CN 00816753A CN 1471580 A CN1471580 A CN 1471580A
- Authority
- CN
- China
- Prior art keywords
- peptide
- virus
- epi
- virus particle
- exogenous peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9924352.9A GB9924352D0 (en) | 1999-10-14 | 1999-10-14 | Methods,compositions and applications relating to the generation of novel plant viral particles |
GB9924352.9 | 1999-10-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2009101426265A Division CN101591647A (zh) | 1999-10-14 | 2000-10-13 | 含有外源性内表位的病毒颗粒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1471580A true CN1471580A (zh) | 2004-01-28 |
Family
ID=10862753
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA008167532A Pending CN1471580A (zh) | 1999-10-14 | 2000-10-13 | 含有外源性内表位的病毒颗粒 |
CNA2009101426265A Pending CN101591647A (zh) | 1999-10-14 | 2000-10-13 | 含有外源性内表位的病毒颗粒 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2009101426265A Pending CN101591647A (zh) | 1999-10-14 | 2000-10-13 | 含有外源性内表位的病毒颗粒 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1235910A1 (xx) |
JP (1) | JP2003534771A (xx) |
KR (1) | KR100880477B1 (xx) |
CN (2) | CN1471580A (xx) |
AR (1) | AR026066A1 (xx) |
AU (1) | AU785020B2 (xx) |
BR (1) | BR0014861A (xx) |
CA (1) | CA2387626A1 (xx) |
CO (1) | CO5280142A1 (xx) |
CZ (1) | CZ20021303A3 (xx) |
GB (1) | GB9924352D0 (xx) |
IL (1) | IL149077A0 (xx) |
MX (1) | MXPA02003789A (xx) |
PL (1) | PL354933A1 (xx) |
WO (1) | WO2001027282A1 (xx) |
ZA (1) | ZA200202815B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000855A2 (en) * | 2001-06-21 | 2003-01-03 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
MXPA05000287A (es) | 2002-07-05 | 2005-09-08 | Leclerc Denis | Particula viral adyuvante. |
US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
CA2583113C (en) | 2004-10-05 | 2015-11-10 | Diversa Corporation | Compositions comprising an antigen and a promiscuous t-cell epitope |
EP1885394A4 (en) * | 2005-06-01 | 2009-10-21 | Dow Global Technologies Inc | PRODUCTION OF MULTIVALENT PARTICLES LIKE VIRUSES |
CN101227920A (zh) * | 2005-07-19 | 2008-07-23 | 陶氏环球技术公司 | 重组流感疫苗 |
US20090093019A1 (en) * | 2007-04-27 | 2009-04-09 | Phelps Jamie P | Production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
WO2013003353A2 (en) * | 2011-06-30 | 2013-01-03 | Stc.Unm | Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
GB9712282D0 (en) * | 1997-06-12 | 1997-08-13 | Innes John Centre Innov Ltd | Epitope presentation system |
-
1999
- 1999-10-14 GB GBGB9924352.9A patent/GB9924352D0/en not_active Ceased
-
2000
- 2000-10-13 IL IL14907700A patent/IL149077A0/xx unknown
- 2000-10-13 BR BR0014861-0A patent/BR0014861A/pt not_active Application Discontinuation
- 2000-10-13 KR KR1020027004778A patent/KR100880477B1/ko not_active IP Right Cessation
- 2000-10-13 EP EP00972153A patent/EP1235910A1/en not_active Withdrawn
- 2000-10-13 CA CA002387626A patent/CA2387626A1/en not_active Abandoned
- 2000-10-13 CN CNA008167532A patent/CN1471580A/zh active Pending
- 2000-10-13 CZ CZ20021303A patent/CZ20021303A3/cs unknown
- 2000-10-13 PL PL00354933A patent/PL354933A1/xx unknown
- 2000-10-13 CN CNA2009101426265A patent/CN101591647A/zh active Pending
- 2000-10-13 WO PCT/US2000/028430 patent/WO2001027282A1/en active Application Filing
- 2000-10-13 AU AU10852/01A patent/AU785020B2/en not_active Ceased
- 2000-10-13 MX MXPA02003789A patent/MXPA02003789A/es unknown
- 2000-10-13 JP JP2001530485A patent/JP2003534771A/ja active Pending
- 2000-10-17 AR ARP000105455A patent/AR026066A1/es unknown
- 2000-10-17 CO CO00078905A patent/CO5280142A1/es not_active Application Discontinuation
-
2002
- 2002-04-10 ZA ZA200202815A patent/ZA200202815B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL149077A0 (en) | 2002-11-10 |
GB9924352D0 (en) | 1999-12-15 |
WO2001027282A1 (en) | 2001-04-19 |
AR026066A1 (es) | 2002-12-26 |
BR0014861A (pt) | 2002-07-16 |
AU785020B2 (en) | 2006-08-24 |
PL354933A1 (en) | 2004-03-22 |
AU1085201A (en) | 2001-04-23 |
CN101591647A (zh) | 2009-12-02 |
CO5280142A1 (es) | 2003-05-30 |
ZA200202815B (en) | 2003-08-27 |
EP1235910A1 (en) | 2002-09-04 |
JP2003534771A (ja) | 2003-11-25 |
CA2387626A1 (en) | 2001-04-19 |
KR100880477B1 (ko) | 2009-01-28 |
CZ20021303A3 (cs) | 2002-10-16 |
MXPA02003789A (es) | 2002-09-30 |
KR20020040868A (ko) | 2002-05-30 |
WO2001027282A8 (en) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103031310B (zh) | 在植物中表达蛋白质 | |
CN109321582B (zh) | 粗山羊草Yr4DS基因在麦族植物抗条锈病育种的应用 | |
KR102162118B1 (ko) | 식물에서 로타바이러스-유사 입자 생산 | |
CN1927394A (zh) | 口服重组幽门螺杆菌疫苗及其制备方法 | |
CN111727255A (zh) | 修饰后诺如病毒vp1蛋白和包含修饰后诺如病毒vp1蛋白的vlp | |
KR20100044813A (ko) | 돼지 부종병 백신 | |
US20210388366A1 (en) | Plant-produced chimaeric orbivirus vlps | |
CA2264489A1 (en) | Plant retroviral polynucleotides and methods for use thereof | |
CN1471580A (zh) | 含有外源性内表位的病毒颗粒 | |
CN1923850A (zh) | 水稻叶形控制基因sll1及其应用 | |
CN1079779A (zh) | 新的植物启动子 | |
CN1162979A (zh) | Dna序列及其用途 | |
CN1772902A (zh) | 轮状病毒vp6蛋白的一种编码基因及其应用 | |
WO2008035210A2 (en) | Recombinant hbsag virus-like particles containing polyepitopes of interest, their production and use | |
CN1229139A (zh) | 葡萄糖氧化酶基因在培育抗病转基因植物中的应用 | |
CN112813092B (zh) | GbBCCP5蛋白质及其编码基因在调控生物油脂含量中的应用 | |
CN101988058B (zh) | 一种基因表达组合物、猪生殖与呼吸道综合症口服疫苗及其制备方法 | |
CN1379783A (zh) | 通过功能性地抑制植物细胞周期蛋白抑制剂基因增加植物细胞增殖的方法 | |
KR20170104595A (ko) | 식물에서 로타바이러스-유사 입자 생산 | |
US7135282B1 (en) | Viral particles with exogenous internal epitopes | |
CN1280457A (zh) | 葡萄树中的线虫传多面体病毒抗性 | |
CN1110559C (zh) | 调控金黄担子素敏感性的基因 | |
CN1571839A (zh) | 利用可见光修复紫外线损伤的dna的酶基因 | |
CN1624141A (zh) | 提高轮状病毒vp7或vp4植物表达含量的方法及产品 | |
TW202018084A (zh) | 修飾之諾羅病毒vp1蛋白及包含修飾之諾羅病毒vp1蛋白之vlp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |